← Retour à la une
Amériques · Presse financière · The Globe and Mail (Report on Business)

Competition Bureau does not penalize Express Scripts, but raises concern about exclusive pharmacy deals

Publié par The Globe and Mail (Report on Business) · Canada il y a 1 h
The Competition Bureau did not find wrongdoing in its investigation of Express Scripts, but says preferred provider networks could raise issues in other cases.Jacques Boissinot/The Canadian Press
The Competition Bureau did not find wrongdoing in its investigation of Express Scripts, but says preferred provider networks could raise issues in other cases.Jacques Boissinot/The Canadian Press · The Globe and Mail (Report on Business)

Résumé détaillé

Watchdog was probing whether company required customers to use certain pharmacies, or imposed fees that harmed competition

The federal Competition Bureau has concluded an investigation into Express Scripts Canada, a large player in managing insurance claims at drugstore checkouts, saying it found insufficient evidence of wrongdoing but “remains concerned about the potential harm to competition” resulting from deals to steer patients to particular pharmacies.

Express Scripts is the country’s largest “pharmacy benefit manager,” a commonly used middleman between pharmacies and insurers.

PBMs process claims for insurers, which means that drug coverage can be applied at a pharmacy checkout, and customers with insurance do not have to pay out of pocket for the full costs of their drugs.

Pharmacy benefit managers also sometimes set up or manage “preferred provider networks,” a controversial type of deal between insurers and pharmacies that can require people to visit a certain pharmacy in order to be reimbursed for their medications.

Express Scripts Canada is a subsidiary of U.S.-based Express Scripts Holding Co., which is owned by U.S. insurance company Cigna Group. The company also operates mail-order pharmacies in Canada.

In early 2024, the bureau began receiving complaints claiming Express Scripts was abusing its dominance of the market by imposing mandatory fees on retail pharmacies. Complaints also raised concerns about the growth of preferred provider networks in Canada. The watchdog launched its investigation in response.

The investigation looked into two different questions: first, did Express Scripts use PPN deals to force patients to fill prescriptions at its own mail-order pharmacies or associated pharmacies, rather then their pharmacy of choice? And did Express Scripts “squeeze” competing pharmacies’ profits by imposing fees for its PBM services, or through auditing practices? Pharmacists had complained that these audits in some cases clawed back reimbursement claims for prescriptions that were previously verified.

In late 2024, the Competition Bureau also made a submission to an…

“Based…

Début de l'article, extrait de The Globe and Mail (Report on Business). Pour lire la suite, ouvrez l'article chez le média.

Lire l'article complet sur The Globe and Mail (Report on Business) Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.theglobeandmail.com)

À lire aussi